HOME Top Market Reports Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021

Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: July 2016
Report Code: BT 4447

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global stem cell biobanking market is estimated to be valued at USD 1.58 Billion in 2016 and projected to grow at a CAGR of 20.2% from 2016 to reach USD 3.96 Billion by 2021. The storage services sector holds the largest market share in the stem cell biobanking market. Increasing awareness regarding the storage of cord blood and tissue stem cells, high growth potential of emerging economies, and increasing use of stem cells in the field of therapeutics have opened an array of opportunities for the growth of the market in coming years.

The objective of stem cell banking market report is to identify various services and applications related to this market across industries and analyze the complete global overview of the stem cell biobanking market. It involves an in-depth analysis of the market segmentation based on bank types, services, applications, and geographies. The report also provides a detailed competitive landscape of the key players operating in this market.

Stem cell banking market research study involved the extensive use of secondary sources, directories, and databases, such as Hoovers, Bloomberg Business, and Factiva to identify and collect information useful for this technical, market-oriented, and commercial study of the global stem cell biobanking market. Primary sources are mainly industry experts from core and related industries and preferred suppliers, distributors, service providers, technology developers, alliances, standards and certification organizations, and organizations related to all segments of this industry’s value chain.

In-depth interviews were conducted from various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and assess future prospects.

Stem Cell Banking Market

To know about the assumptions considered for the study, download the pdf brochure

The major market players covered in this report are StemCyte (U.S.), Cryo-Cell International (U.S.), ViaCord (By Perkin Elmer) (U.S.), Cord Blood Registry (U.S.), Smart Cells (U.K.), Cryo-Save (Netherlands), Cryoviva (India), LifeCell (India), Cordlife (Singapore), Cordvida (Brazil), and China Cord Blood Corporation (China).

Stakeholders

  • Government and research organizations
  • Hospitals
  • Clinics
  • Private medical offices
  • Companies in the stem cell banking sector

“This report answers several questions for stakeholders primarily, which market segments to focus on in the next two to five years for prioritizing efforts and investments.”

Scope of the Report:

This report categorizes the stem cell biobanking market on the basis of service type, application, and region.

Market Segmentation, by Type: Based on type, the stem cell biobanking market has been segmented into:

  • Cord Blood
  • Cord Blood & Cord Tissue

Market Segmentation, by Service Type: Based on service type, the stem cell biobanking market has been segmented into:

  • Collection and Transportation
  • Processing
  • Analysis
  • Storage

Market Segmentation, by Application: Based on application, the stem cell biobanking market has been segmented into:

  • Cerebral Palsy
  • Leukemia
  • Thalassemia
  • Anemia
  • Autism
  • Diabetes
  • Others

Market Segmentation, by Region: The regional analysis covers:

  • North America
  • Europe
  • Asia
  • Rest of the World (RoW)

Customization Options:

Along with market data, customize MnM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a detailed analysis of the following parameters: product analysis, brand/product perception matrix, Porter’s five forces analysis, regulatory framework, and competitive intelligence.

Table of Contents

1 Introduction (Page No. - 12)
    1.1 Objective of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered in the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 15)
    2.1 Research Data
           2.1.1 Key Data From Secondary Sources
           2.1.2 Key Data From Primary Sources
                    2.1.2.1 Breakdown of Primary Interviews
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions
           2.4.1 Assumptions

3 Executive Summary (Page No. - 23)

4 Premium Insights (Page No. - 25)
    4.1 Attractive Opportunities in the Stem Cell Banking Market

5 Market Overview (Page No. - 28)
    5.1 Market Segmentation
           5.1.1 Stem Cell Banking, By Bank Type
           5.1.2 Stem Cell Banking, By Service
           5.1.3 Stem Cell Banking, By Application
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Easy Extraction Methods
                    5.2.1.2 Rising Number of Newborns
                    5.2.1.3 Growth in Gdp, Disposable Income, and Increased Awareness of Stem Cell Therapeutics
                    5.2.1.4 Potential of Stem Cells in Disease Treatment
           5.2.2 Restraints
                    5.2.2.1 High Competition in the Stem Cell Banking Market
                    5.2.2.2 High Operating Cost
                    5.2.2.3 Lack of Acceptance
                    5.2.2.4 Changes in Legal Regulations
           5.2.3 Opportunities
                    5.2.3.1 Rising Awareness About Potential Use of Cord Tissue
                    5.2.3.2 Collaborations Among Cord Blood Banks
                    5.2.3.3 The Automation of Procedures
           5.2.4 Challenges
                    5.2.4.1 Entry Barriers in the Market

6 Stem Cell Banking Market, By Bank Type (Page No. - 34)
    6.1 Introduction
    6.2 Cord Blood
    6.3 Cord Tissue

7 Market By Service (Page No. - 43)
    7.1 Introduction
    7.2 Collection & Transportation
    7.3 Processing
    7.4 Analysis
    7.5 Storage

8 Stem Cell Banking Market, By Application (Page No. - 52)
    8.1 Introduction
    8.2 Cerebral Palsy
    8.3 Thalassemia
    8.4 Leukemia
    8.5 Diabetes
    8.6 Autism
    8.7 Others

9 Stem Cell Banking Market, By Region (Page No. - 67)
    9.1 Introduction
    9.2 North America
           9.2.1 North America, By Country
           9.2.2 North America, By Type
           9.2.3 North America, By Service
           9.2.4 North America, By Application
    9.3 Europe
           9.3.1 Europe, By Country
           9.3.2 Europe, By Type
           9.3.3 Europe, By Service
           9.3.4 Europe, By Application
    9.4 Asia-Pacific
           9.4.1 Asia-Pacific, By Country
           9.4.2 Asia-Pacific, By Type
           9.4.3 Asia-Pacific, By Service
           9.4.4 Asia-Pacific, By Application
    9.5 Rest of The World (RoW)
           9.5.1 Rest of the World, By Type
           9.5.2 Rest of the World, By Service
           9.5.3 Rest of the World, By Application

10 Competitive Landscape (Page No. - 85)
     10.1 Company Share Analysis
     10.2 New Service/Product Launches
     10.3 Mergers & Acquisitions
     10.4 Regulatory Approvals
     10.5 Partnerships
     10.6 Joint Venture
     10.7 Agreements
     10.8 Collaborations
     10.9 Technological Update
     10.10 Patent
     10.11 Geographical Expansion
     10.12 Others

11 Company Profile (Page No. - 91)
(Company at A Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MnM View)*
     11.1 CBR Systems, Inc.
     11.2 Cordlife
     11.3 Cryo-Cell
     11.4 Cryo-Save AG (A Group of Esperite)
     11.5 Lifecell
     11.6 Stemcyte
     11.7 Viacord
     11.8 Smart Cells International Ltd.
     11.9 Cryoviva India
     11.10 Cordvida
     11.11 China Cord Blood Corporation

*Details on Company at A Glance, Recent Financials, Products Offered, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 112)
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports


List of Tables (62 Tables)

Table 1 Global Stem Cell Banking Market, By Bank Type, 2014-2021 (Units)
Table 2 Market Volume, By Bank Type, 2016 (%)
Table 3 Market, By Bank Type, 2014-2021 (USD Million)
Table 4 Market Value, By Bank Type, 2016 (%)
Table 5 Cord Blood Stem Cell Biobanking Market, By Region, 2014-2021 (Units)
Table 6 Cord Blood Stem Cell Banking Market Volume, By Region, 2016 (%)
Table 7 Cord Blood Stem Cell Banking Market, By Region, 2014-2021 (USD Million)
Table 8 Cord Blood Market Value, By Region, 2016 (%)
Table 9 Global Cord Blood & Cord Tissue Stem Cell Banking Market, By Region, 2014-2021 (Units)
Table 10 Cord Blood & Cord Tissue Stem Cell Biobanking Market Volume, By Region, 2016 (%)
Table 11 Global Cord Blood & Cord Tissue Stem Cell Banking Market, By Region, 2014-2021 (USD Million)
Table 12 Cord Blood & Cord Tissue Market Value, By Region, 2016 (%)
Table 13 Market  By Services, 2014-2021 (USD Million)
Table 14 Market Value, By Services, 2016 & 2021 (%)
Table 15 Market for Collection & Transportation, By Region, 2014-2021 (USD Million)
Table 16 Market for Processing, By Region, 2014-2021 (USD Million)
Table 17 Market for Analysis, By Region, 2014-2021 (USD Million)
Table 18 Market for Storage, By Region, 2014-2021 (USD Million)
Table 19 Number of Samples Used for Application, 2014-2021 (Units)
Table 20 Market, By Application, 2014-2021 (Units)
Table 21 Market, By Application, 2014-2021 (%)
Table 22 Number of Stem Cell Units Released for Application Market, By Region, 2014-2021 (Units)
Table 23 Number of Clinical Trials Using Stem Cells From Cord Blood and Cord Tissue in Cerebral Palsy Treatment From 2014-2016
Table 24 Market in Cerebral Palsy, By Region, 2014-2021 (Units)
Table 25 Market in Thalassemia, By Region, 2014-2021 (Units)
Table 26 Market in Leukemia, By Region, 2014-2021 (Units)
Table 27 Market in Anemia, By Region, 2014-2021 (Units)
Table 28 Market in Diabetes, By Region, 2014-2021 (Units)
Table 29 Market in Autism, By Region, 2014-2021 (Units)
Table 30 Market in Others, By Region, 2014-2021 (Units)
Table 31 Market, Overview, 2014-2021
Table 32 Market, By Region, 2014-2021 (Units)
Table 33 Market Volume, By Region, 2014-2021 (%)
Table 34 Market, By Region, 2014-2021 (USD Million)
Table 35 Market Value, By Region, 2014-2021 (%)
Table 36 North America Market, By Country, 2014-2021 (Units)
Table 37 North America Market, By Country, 2014-2021 (USD Million)
Table 38 North America Market, By Type, 2014-2021 (Units)
Table 39 North America Market, By Type, 2014-2021 (USD Million)
Table 40 North America Market, By Service, 2014 -2021 (USD Million)
Table 41 North America Market, Usage, 2014-2021
Table 42 North America Market, By Application, 2014-2021 (Units)
Table 43 Europe Market, By Country, 2014-2021 (Units)
Table 44 Europe Market, By Country, 2014-2021 (USD Million)
Table 45 Europe Market, By Type, 2014-2021 (Units)
Table 46 Europe Market, By Type, 2014-2021 (USD Million)
Table 47 Europe Market, By Service, 2014 -2021 (USD Million)
Table 48 Europe Market, Usage, 2014-2021
Table 49 Europe Market, By Application, 2014-2021 (Units)
Table 50 Asia-Pacific Market, By Country, 2014-2021 (Units)
Table 51 Asia-Pacific Market, By Country, 2014-2021 (USD Million)
Table 52 Asia-Pacific Market, By Type, 2014-2021 (Units)
Table 53 Asia-Pacific Market, By Type, 2014-2021 (USD Million)
Table 54 Asia-Pacific Market, By Service, 2014 -2021 (USD Million)
Table 55 Asia-Pacific Market, Usage, 2014-2021
Table 56 Asia-Pacific Market, By Application, 2014-2021 (Units)
Table 57 Rest of the World Market, By Type, 2014-2021 (Units)
Table 58 Rest of the World Market, By Type, 2014-2021 (USD Million)
Table 59 Rest of the World Market, By Service, 2014 -2021 (USD Million)
Table 60 Rest of the World Market, Usage, 2014-2021
Table 61 Rest of the World Market, By Application, 2014-2021 (Units)
Table 62 Market: Company Share Analysis, 2015 (%)


List of Figures (40 Figures)

Figure 1 Market: Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation,& Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Global Market to Witness High Growth During the Forecast Period
Figure 6 The Processing Services Segment Expected to Lead the Market in 2016
Figure 7 Asia-Pacific to Witness the Highest Growth Rate During the Forecast Period
Figure 8 Market, By Bank Type, 2016 & 2021 (Units)
Figure 9 Market, By Bank Type, 2016 & 2021 (USD Million)
Figure 10 Cord Blood Market, By Region, 2016 & 2021 (Units)
Figure 11 Cord Blood Market, By Region, 2016 & 2021 (USD Million)
Figure 12 Cord Blood & Cord Tissue Stem Cell Banking Market, By Region, 2016 & 2021 (Units)
Figure 13 Cord Blood & Cord Tissue Stem Cell Banking Market, By Region, 2016 & 2021 (USD Million)
Figure 14 Market, By Services
Figure 15 Processing Segment Expected to Continue Leading the Market During Forecast Period
Figure 16 Market for Collection & Transportation, By Region, 2016 & 2021 (USD Million)
Figure 17 Processing is Expected to Be the Largest Segment of the North American Market
Figure 18 Market for Analysis, By Region, 2016 & 2021 (USD Million)
Figure 19 Market for Storage, By Region, 2016 & 2021, (USD Million)
Figure 20 Largest Number of Stem Cells are Expected to Be Utilized to Treat Leukemia By 2021 Globally
Figure 21 North America to Continue Leading the Application Segment of the Market During Forecast Period
Figure 22 Cerebral Palsy is Expected to Use the Largest Number of Stem Cell Units in 2016
Figure 23 North America is Estimated to Lead the Market in Thalassemia in 2016
Figure 24 Largest Number of Stem Cells From Cord Blood to Be Consumed for Leukemia Treatment
Figure 25 Stem Cell Banking Market in Anemia, By Region, 2016 & 2021 (Units)
Figure 26 Diabetes is Expected to Be the Fastest Growing Segment of Market During Forecast Period
Figure 27 Stem Cell Banking Market in Autism, By Region, 2016 & 2021 (Units)
Figure 28 Stem Cell Banking Market in Others, By Region, 2016 & 2021 (Units)
Figure 29 Asia-Pacific is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 30 North America Will Continue to Dominate the Stem Cell Banking Market During Forecast Period
Figure 31 North America Stem Cell Banking Market Snapshot
Figure 32 Europe Stem Cell Banking Market Snapshot
Figure 33 Asia-Pacific Stem Cell Banking Market Snapshot
Figure 34 Stem Cell Banking Market: Company Share Analysis, 2015 (%)
Figure 35 CBR Systems, Inc.: Business Overview
Figure 36 Cordlife: Business Overview
Figure 37 Cryo-Cell: Business Overview
Figure 38 Cryo-Save AG (A Group of Esperite): Business Overview
Figure 39 Viacord: Business Overview
Figure 40 China Cord Blood Corporation: Business Overview

The global stem cell banking market is expected to reach USD 3.96 Billion by 2021 from USD 1.58 Billion in 2016, at a CAGR of 20.2% from 2016 to 2021. Increasing awareness regarding the storage of cord blood and tissue stem cells, high growth potential of emerging economies, and increasing use of stem cells in the field of therapeutics have opened an array of opportunities for the growth of the market in the coming years.

The global stem cell banking market is classified on the basis of type into cord blood and cord blood & cord tissue. On the basis of services, the market is segmented into collection & transportation, processing, analysis, and storage. The major applications of stem cell banking include cerebral palsy, leukemia, thalassemia, anemia, autism, diabetes, and others. Among these applications, stem cells are mainly used for the treatment of cerebral palsy.

The storage services segment is estimated to command the largest share in 2016 and the forecast period. North America is the major market for this segment. The high share of the storage services segment can be attributed to the high cost of the equipment required for the storage of cord blood and cord tissue, in turn increasing the per-year cost of maintenance of the sample units.

By region, the report segments the stem cell banking market into four regions–North America, Europe, Asia-pacific, and the Rest of the World. Among these regions, North America holds the largest market share. This is attributed to factors such as availability of federal funding for stem cell research. In addition, the preference for private banks has risen in the U.S.; in 2013, 2.6% of parents were opting for private banks as opposed to 0.4% in 2004. Moreover, an FDA-approved clinical trial showed that the use of stem cells helped improve impaired sight in 2014 and provide the safety of stem cell therapy in the long run.

Stem Cell Banking Market

A key restraint to market growth is the high cost of storage. The approximate cost incurred in storing cells for 25 years is USD 1,500 with a USD 150 per-year maintenance charge. In addition, the cost of cell therapies to treat diseases is high, with no guaranteed success due to the variability of the samples even after standardization checks. Based on a company’s operating facilities, the cost of processing and storage of samples might further increase.

The major players operating in the stem cell banking market include StemCyte (U.S.), Cryo-Cell International (U.S.), ViaCord (By Perkin Elmer) (U.S.), Cord Blood Registry (U.S.), Smart Cells (U.K.), Cryo-Save (Europe), Cryoviva (India), LifeCell (India), Cordlife (Singapore), Cordvida (Brazil), and China Cord Blood Corporation (China).

Cord Blood Registry, San Bruno, (U.S.) accounted for the largest share of the stem cell banking market in 2015. It is the largest bank for the storage of umbilical cord blood and cord blood tissue, with more than 600,000 units stored till date.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo